Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication
- PMID: 34237252
- DOI: 10.1016/j.cmet.2021.06.005
Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication
Abstract
Liver fibrosis is a strong predictor of long-term mortality in individuals with metabolic-associated fatty liver disease; yet, the mechanisms underlying the progression from the comparatively benign fatty liver state to advanced non-alcoholic steatohepatitis (NASH) and liver fibrosis are incompletely understood. Using cell-type-resolved genomics, we show that comprehensive alterations in hepatocyte genomic and transcriptional settings during NASH progression, led to a loss of hepatocyte identity. The hepatocyte reprogramming was under tight cooperative control of a network of fibrosis-activated transcription factors, as exemplified by the transcription factor Elf-3 (ELF3) and zinc finger protein GLIS2 (GLIS2). Indeed, ELF3- and GLIS2-controlled fibrosis-dependent hepatokine genes targeting disease-associated hepatic stellate cell gene programs. Thus, interconnected transcription factor networks not only promoted hepatocyte dysfunction but also directed the intra-hepatic crosstalk necessary for NASH and fibrosis progression, implying that molecular "hub-centered" targeting strategies are superior to existing mono-target approaches as currently used in NASH therapy.
Keywords: Cell type-specific profiling; ELF3; GLIS2; genomic reprogramming; hepatocytes; liver fibrosis; metabolic-associated fatty liver disease; nonalcoholic steatohepatitis; transcription factor networks.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD).Int J Mol Sci. 2022 Jun 23;23(13):6996. doi: 10.3390/ijms23136996. Int J Mol Sci. 2022. PMID: 35805998 Free PMC article. Review.
-
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.J Hepatol. 2020 Oct;73(4):896-905. doi: 10.1016/j.jhep.2020.04.037. Epub 2020 May 4. J Hepatol. 2020. PMID: 32376414
-
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.Cell Metab. 2016 Dec 13;24(6):848-862. doi: 10.1016/j.cmet.2016.09.016. Epub 2016 Oct 27. Cell Metab. 2016. PMID: 28068223 Free PMC article.
-
Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression.J Clin Invest. 2024 Apr 1;134(7):e166731. doi: 10.1172/JCI166731. J Clin Invest. 2024. PMID: 38557493 Free PMC article.
-
Nonalcoholic Steatohepatitis.Annu Rev Med. 2017 Jan 14;68:85-98. doi: 10.1146/annurev-med-051215-031109. Epub 2016 Oct 5. Annu Rev Med. 2017. PMID: 27732787 Review.
Cited by
-
Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis.PLoS Pathog. 2024 Sep 27;20(9):e1012565. doi: 10.1371/journal.ppat.1012565. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39331683 Free PMC article.
-
Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma.JHEP Rep. 2023 Jun 9;5(9):100811. doi: 10.1016/j.jhepr.2023.100811. eCollection 2023 Sep. JHEP Rep. 2023. PMID: 37575883 Free PMC article. Review.
-
Indirubin alleviates CCl4-induced liver fibrosis by regulation of TGF-β-mediated signaling pathways.Iran J Basic Med Sci. 2023;26(9):1047-1052. doi: 10.22038/IJBMS.2023.70476.15319. Iran J Basic Med Sci. 2023. PMID: 37605732 Free PMC article.
-
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming.J Hepatol. 2023 Sep;79(3):728-740. doi: 10.1016/j.jhep.2023.04.013. Epub 2023 Apr 23. J Hepatol. 2023. PMID: 37088308 Free PMC article.
-
Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression.Toxicol Sci. 2024 Aug 1;200(2):324-345. doi: 10.1093/toxsci/kfae057. Toxicol Sci. 2024. PMID: 38710495
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases